JP2007501279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007501279A5 JP2007501279A5 JP2006533257A JP2006533257A JP2007501279A5 JP 2007501279 A5 JP2007501279 A5 JP 2007501279A5 JP 2006533257 A JP2006533257 A JP 2006533257A JP 2006533257 A JP2006533257 A JP 2006533257A JP 2007501279 A5 JP2007501279 A5 JP 2007501279A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- group
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C[C@@](C1)C2c3c(*)cc(**)cc3OC(*)(*)C2CCC1*=C Chemical compound C[C@@](C1)C2c3c(*)cc(**)cc3OC(*)(*)C2CCC1*=C 0.000 description 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47231603P | 2003-05-20 | 2003-05-20 | |
| PCT/US2004/015885 WO2004113320A1 (en) | 2003-05-20 | 2004-05-20 | Cannabinoid derivatives, methods of making, and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007501279A JP2007501279A (ja) | 2007-01-25 |
| JP2007501279A5 true JP2007501279A5 (https=) | 2007-08-30 |
Family
ID=33539041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533257A Pending JP2007501279A (ja) | 2003-05-20 | 2004-05-20 | カンナビノイド誘導体、その製造方法、および使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7169942B2 (https=) |
| EP (1) | EP1633733B1 (https=) |
| JP (1) | JP2007501279A (https=) |
| CN (1) | CN1809552A (https=) |
| AT (1) | ATE496901T1 (https=) |
| AU (1) | AU2004249669B2 (https=) |
| CA (1) | CA2526103A1 (https=) |
| DE (1) | DE602004031221D1 (https=) |
| DK (1) | DK1633733T3 (https=) |
| WO (1) | WO2004113320A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1727900A4 (en) * | 2004-03-26 | 2008-05-28 | Fujifilm Corp | METHOD FOR SELECTIVELY SEPARATING AND CLEANING RNA, AND METHOD FOR SEPARATING AND CLEANING NUCLEIC ACID |
| US20060257337A1 (en) * | 2005-04-28 | 2006-11-16 | David Sherris | Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis |
| USRE46558E1 (en) | 2005-04-28 | 2017-09-26 | Paloma Pharmaceuticals, Inc. | Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| CA2623723A1 (en) | 2005-09-29 | 2007-04-12 | Amr Technology, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| DE102005062098A1 (de) * | 2005-12-22 | 2007-06-28 | Merck Patent Gmbh | Oxaphenanthren-Derivate |
| JP2009528381A (ja) * | 2006-02-28 | 2009-08-06 | パロマ ファーマシューティカルズ，インク． | 細胞増殖および血管新生を特徴とする疾患を治療する組成物および方法 |
| CN101668425A (zh) | 2007-03-02 | 2010-03-10 | 田纳西州立大学研究基金会 | 三芳基/杂芳族大麻素类和其应用 |
| US20110021618A1 (en) * | 2008-03-25 | 2011-01-27 | Paloma Pharmaceuticals, Inc. | Methods of treating fibrotic disorders |
| US8476439B2 (en) | 2008-05-19 | 2013-07-02 | The University Of Tennessee Research Foundation | Pyridine classical cannabinoid compounds and related methods of use |
| US8389534B2 (en) * | 2008-05-19 | 2013-03-05 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| US8541431B2 (en) * | 2008-05-19 | 2013-09-24 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| JP2011520974A (ja) * | 2008-05-19 | 2011-07-21 | ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ | ピリミジンの古典的カンナビノイド化合物及び関連する使用方法 |
| CA2724697A1 (en) * | 2008-05-19 | 2009-11-26 | University Of Tennessee Research Foundation, The | Pyridine classical cannabinoid compounds and related methods of use |
| US8349876B2 (en) | 2008-05-19 | 2013-01-08 | The University Of Tennesee Research Foundation | Pyridine non-classical cannabinoid compounds and related methods of use |
| US8158654B2 (en) | 2008-05-19 | 2012-04-17 | The University Of Tennessee Research Foundation | Pyridine non-classical cannabinoid compounds and related methods of use |
| US9623000B2 (en) | 2008-07-31 | 2017-04-18 | Dekel Pharmaceuticals Ltd | Compositions and methods for treating inflammatory disorders |
| US9381187B2 (en) | 2011-02-16 | 2016-07-05 | Paloma Pharmaceuticals, Inc. | Radiation countermeasure agents |
| CN103110582A (zh) * | 2013-03-04 | 2013-05-22 | 上海医药工业研究院 | 大麻酚类化合物微乳剂及其制备方法 |
| EP3160445B1 (en) | 2014-06-26 | 2021-10-20 | Island Breeze Systems Ca, LLC | Mdi related products and methods of use |
| US10059683B2 (en) * | 2015-07-10 | 2018-08-28 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US20180169061A1 (en) * | 2016-12-15 | 2018-06-21 | Ascent Pharmaceuticals, Inc. | Non-aqueous delta9-tetrahydrocannabinol oral liquid formulations |
| AU2018323861B2 (en) * | 2017-08-27 | 2023-08-17 | Rhodes Technologies | Pharmaceutical compositions for the treatment of ophthalmic conditions |
| CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| JP2021535203A (ja) | 2018-08-20 | 2021-12-16 | ベッソール ファルマ、エルエルシー | 既知および新規カンナビノイドの適用 |
| WO2020077153A1 (en) | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
| CN110269839A (zh) * | 2019-06-15 | 2019-09-24 | 云南飞久逍科技有限公司 | 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用 |
| CA3156487A1 (en) * | 2019-10-03 | 2021-04-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | LIPOSOMAL CANNABINOIDS AND ASSOCIATED USES |
| IL292775A (en) | 2019-11-08 | 2022-07-01 | Vella Bioscience Inc | preparations containing cannabidiol (cbd) that act peripherally and their use to improve female sexual function or to treat female sexual disorders |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941782A (en) * | 1972-04-27 | 1976-03-02 | Sharps Associates | Heterocyclic esters of benzopyrans |
| US3915996A (en) * | 1972-10-16 | 1975-10-28 | Abbott Lab | Process for making benzopyrans |
| US3901926A (en) * | 1973-04-02 | 1975-08-26 | Abbott Lab | Alkylphenyl benzopyrans |
| DE4100441A1 (de) * | 1991-01-09 | 1992-07-16 | Mack Chem Pharm | Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol |
| US5596106A (en) | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| DE69822449T2 (de) | 1997-01-21 | 2005-01-27 | Smithkline Beecham Corp. | Neue cannabinoidrezeptor-modulatoren |
| FR2758723B1 (fr) | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| DE19706903A1 (de) | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
| US5948777A (en) | 1997-03-18 | 1999-09-07 | Smithkline Beecham Corporation | Cannabinoid receptor agonists |
| US5939429A (en) | 1997-09-30 | 1999-08-17 | Virginia Commonwealth University | Cardiovascular uses of cannabinoid compounds |
| CA2340445A1 (en) * | 1998-05-04 | 1999-11-11 | The University Of Connecticut | Novel analgesic and immunomodulatory cannabinoids |
| WO2001003690A1 (en) | 1999-07-12 | 2001-01-18 | Virginia Commonwealth University | Novel vasodilator cannabinoid analogs |
| FR2799124B1 (fr) | 1999-10-01 | 2004-08-13 | Sanofi Synthelabo | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| IL132661A (en) | 1999-10-31 | 2008-11-26 | Raphael Mechoulam | Agonists specific for peripheral cannabinoid receptors |
| FR2804604B1 (fr) | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
| WO2001058869A2 (en) | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| US20040039048A1 (en) | 2000-02-11 | 2004-02-26 | Manuel Guzman Pastor | Therapy with cannabinoid compounds for the treatment of brain tumors |
| US6448288B1 (en) | 2000-05-17 | 2002-09-10 | University Of Massachusetts | Cannabinoid drugs |
| DE60125541T2 (de) * | 2000-06-22 | 2007-10-11 | Pharmos Corp. | Neue nicht psychotropische cannabinoide |
| US7067539B2 (en) | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
| US7507767B2 (en) | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| US6509367B1 (en) | 2001-09-22 | 2003-01-21 | Virginia Commonwealth University | Pyrazole cannabinoid agonist and antagonists |
| CN100567266C (zh) | 2001-11-14 | 2009-12-09 | 先灵公司 | 类大麻苷受体配体 |
| DE60319714T2 (de) | 2002-06-19 | 2009-04-02 | Schering Corp. | Agonisten des cannabinoidrezeptors |
| US20040077650A1 (en) | 2002-10-18 | 2004-04-22 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
-
2004
- 2004-05-20 CN CNA2004800174008A patent/CN1809552A/zh active Pending
- 2004-05-20 WO PCT/US2004/015885 patent/WO2004113320A1/en not_active Ceased
- 2004-05-20 AT AT04752828T patent/ATE496901T1/de not_active IP Right Cessation
- 2004-05-20 DK DK04752828.6T patent/DK1633733T3/da active
- 2004-05-20 US US10/850,588 patent/US7169942B2/en not_active Expired - Fee Related
- 2004-05-20 AU AU2004249669A patent/AU2004249669B2/en not_active Ceased
- 2004-05-20 EP EP04752828A patent/EP1633733B1/en not_active Expired - Lifetime
- 2004-05-20 CA CA002526103A patent/CA2526103A1/en not_active Abandoned
- 2004-05-20 JP JP2006533257A patent/JP2007501279A/ja active Pending
- 2004-05-20 DE DE602004031221T patent/DE602004031221D1/de not_active Expired - Lifetime
-
2007
- 2007-01-26 US US11/698,665 patent/US20070167514A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007501279A5 (https=) | ||
| TW536534B (en) | Difluoroprostaglandin derivatives and pharmaceutical composition comprising them | |
| JP2791544B2 (ja) | クロプロステノール及びフルプロステノールの各類似体 | |
| JP6065052B2 (ja) | テトラヒドロカルボリン誘導体 | |
| US20180116995A1 (en) | Bicyclic compound and use thereof for medical purposes | |
| WO1998034916A1 (fr) | Derives de 11,15-o-dialkylprostaglandine e, leur procede de production, et medicaments renfermant ceux-ci comme principe actif | |
| CN115160339B (zh) | 醛糖还原酶抑制剂及其使用方法 | |
| AU1976000A (en) | Nonsteroidal antiinflammatories | |
| JPWO1998034916A1 (ja) | １１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤 | |
| AU609139B2 (en) | Anti-inflammatory furanones | |
| KR101561171B1 (ko) | Ｆ-계열 프로스타글란딘의 제조 방법 | |
| JP2002509543A (ja) | 緑内障の治療のための副作用のないプロスタグランジン誘導体 | |
| JP2011037861A (ja) | Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体 | |
| CN1404475A (zh) | 制备西酞普兰的方法 | |
| KR20010070966A (ko) | 이상지혈증, 아테롬성 동맥 경화증 및 당뇨병의 치료에유용한 고리형 화합물, 약제학적 조성물 및 제조방법 | |
| JP2002543114A5 (https=) | ||
| JPH06507608A (ja) | ベンゾフラン誘導体 | |
| EP2669280B1 (en) | Bicyclic compound and use thereof for medical purposes | |
| JP2000505448A (ja) | カンプトテシン誘導体及び抗腫瘍剤としてのその利用 | |
| WO1998057930A1 (en) | Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives | |
| EP0818439B1 (en) | Imide derivatives | |
| JP2006506381A5 (https=) | ||
| JPH037275A (ja) | ２，５，６，７―テトラノル―４，８―インタ―ｍ―フェニレンＰＧＩ↓２誘導体 | |
| CA2259585A1 (en) | Benzimidazole derivatives having eosinophil increment inhibition activity and their use as medicament | |
| JPH1072421A (ja) | イミド誘導体 |